AAUM (Average Assets Under Management) of ₹860.78 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 13.6% | 13.8% | ▲ +0.2% |
| Chemicals & Petrochemicals | 9.2% | 8.7% | ▼ -0.5% |
| Retailing | 7.7% | 8.5% | ▲ +0.7% |
| Financial Technology (Fintech) | 7.3% | 8.2% | ▲ +0.9% |
| Capital Markets | 8.7% | 8.2% | ▼ -0.6% |
| Automobiles | 6.3% | 6.8% | ▲ +0.5% |
| IT - Services | 4.6% | 5.2% | ▲ +0.6% |
| Electrical Equipment | 5.4% | 4.9% | ▼ -0.6% |
| Industrial Products | 5.0% | 4.7% | ▼ -0.3% |
| Auto Components | 3.6% | 3.6% | ● +0.1% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 13.8% | 14.1% | ▲ +0.3% |
| Financial Technology (Fintech) | 8.2% | 9.3% | ▲ +1.1% |
| Chemicals & Petrochemicals | 8.7% | 8.5% | ▼ -0.2% |
| Retailing | 8.5% | 8.2% | ▼ -0.3% |
| Capital Markets | 8.2% | 8.2% | ● +0.0% |
| Automobiles | 6.8% | 6.3% | ▼ -0.5% |
| Electrical Equipment | 4.9% | 5.3% | ▲ +0.4% |
| IT - Services | 5.2% | 4.7% | ▼ -0.5% |
| Auto Components | 3.6% | 4.0% | ▲ +0.4% |
| Industrial Products | 4.7% | 4.0% | ▼ -0.7% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Weight (Aug 2026) |
|---|---|---|---|
| 1 | Symbiotec Pharmalab Limited ₹25.80 L |
Pharmaceuticals & Biotechnology | 0.03% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹37.87 Cr |
Pharmaceuticals & Biotechnology | 3.60% | 4.13% | +0.53% |
| 2 | Bosch Limited ₹30.00 Cr |
Auto Components | 2.76% | 3.27% | +0.51% |
| 3 | One 97 Communications Limited ₹46.36 Cr |
Financial Technology (Fintech) | 4.58% | 5.05% | +0.47% |
| 4 | Hitachi Energy India Limited ₹33.42 Cr |
Electrical Equipment | 3.24% | 3.64% | +0.40% |
| 5 | PB Fintech Limited ₹18.56 Cr |
Financial Technology (Fintech) | 1.69% | 2.02% | +0.33% |
| 6 | Multi Commodity Exchange of India Limited ₹27.54 Cr |
Capital Markets | 2.71% | 3.00% | +0.29% |
| 7 | Pine Labs Limited ₹20.50 Cr |
Financial Technology (Fintech) | 1.94% | 2.23% | +0.29% |
| 8 | Glenmark Pharmaceuticals Limited ₹22.32 Cr |
Pharmaceuticals & Biotechnology | 2.25% | 2.43% | +0.18% |
| 9 | Eternal Limited ₹27.89 Cr |
Retailing | 2.87% | 3.04% | +0.17% |
| 10 | Navin Fluorine International Limited ₹31.23 Cr |
Chemicals & Petrochemicals | 3.30% | 3.40% | +0.10% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Cummins India Limited ₹16.08 Cr |
Industrial Products | 2.47% | 1.75% | -0.72% |
| 2 | AMAGI MEDIA LABS LTD ₹22.98 Cr |
IT - Services | 3.09% | 2.50% | -0.59% |
| 3 | Bajaj Finance Limited ₹22.83 Cr |
Finance | 2.99% | 2.49% | -0.50% |
| 4 | Lenskart Solutions Limited ₹21.46 Cr |
Retailing | 2.82% | 2.34% | -0.48% |
| 5 | Travel Food Services Limited ₹11.70 Cr |
Leisure Services | 1.63% | 1.27% | -0.36% |
| 6 | Ola Electric Mobility Ltd ₹7.48 Cr |
Automobiles | 1.14% | 0.81% | -0.33% |
| 7 | Linde India Limited ₹35.30 Cr |
Chemicals & Petrochemicals | 4.17% | 3.85% | -0.32% |
| 8 | Lupin Limited ₹19.70 Cr |
Pharmaceuticals & Biotechnology | 2.43% | 2.15% | -0.28% |
| 9 | Bharti Airtel Limited ₹18.12 Cr |
Telecom - Services | 2.21% | 1.97% | -0.24% |
| 10 | BSE Limited ₹14.77 Cr |
Capital Markets | 1.83% | 1.61% | -0.22% |
47 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹46.36 Cr |
Financial Technology (Fintech) |
5.05%
|
|
| 2 |
₹37.87 Cr |
Pharmaceuticals & Biotechnology |
4.13%
|
|
| 3 |
₹35.30 Cr |
Chemicals & Petrochemicals |
3.85%
|
|
| 4 |
₹33.42 Cr |
Electrical Equipment |
3.64%
|
|
| 5 |
₹31.61 Cr |
Pharmaceuticals & Biotechnology |
3.44%
|
|
| 6 |
₹31.23 Cr |
Chemicals & Petrochemicals |
3.40%
|
|
| 7 |
₹30.00 Cr |
Auto Components |
3.27%
|
|
| 8 |
₹29.74 Cr |
Automobiles |
3.24%
|
|
| 9 |
₹27.89 Cr |
Retailing |
3.04%
|
|
| 10 |
₹27.54 Cr |
Capital Markets |
3.00%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.